首页> 外文OA文献 >P858 An open-label, multi-center trial of INO-5401 and INO-9012 delivered by electroporation (EP) in combination with cemiplimab in subjects with newly-diagnosed glioblastoma (GBM)

【2h】

P858 An open-label, multi-center trial of INO-5401 and INO-9012 delivered by electroporation (EP) in combination with cemiplimab in subjects with newly-diagnosed glioblastoma (GBM)

机译：P858通过电穿孔（EP）与新诊断的胶质母细胞瘤（GBM）组合电穿孔（EP）与CeMimprain（EP）组合的开放标签，多中心试验和INO-9012。

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Jeffrey Skolnik; David Reardon; Steven Brem; Arati Desai; Stephen Bagley; Sylvia Kurz; Macarena de la Fuente; Seema Nagpal; Mary Welch; Brian Sacchetta; Sarah Bartra; Amy-Lee Bredlau; Israel Lowy; Kimberly Kraynyak; Matthew Morrow; Trevor McMullan; Jean Boyer;
展开▼
作者单位

展开▼
年度 2020
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. P858?An open-label, multi-center trial of INO-5401 and INO-9012 delivered by electroporation (EP) in combination with cemiplimab in subjects with newly-diagnosed glioblastoma (GBM) [J] . Jeffrey Skolnik, David Reardon, Steven Brem, Journal for ImmunoTherapy of Cancer . 2020,第Suppla1期

机译：p858？用电穿孔（EP）与新诊断的胶质母细胞瘤（GBM）组合电穿孔（EP）递送的INO-5401和INO-9012的开放标签，多中心试验
2. Does Early Postsurgical Temozolomide Plus Concomitant Radiochemotherapy Regimen Have Any Benefit in Newly-diagnosed Glioblastoma Patients? A Multi-center,Randomized, Parallel, Open-label, Phase Ⅱ Clinical Trial [J] . Ying Mao, Yu Yao, Li-Wei Zhang, 中华医学杂志（英文版） . 2015,第020期

机译：早期替莫唑胺与伴发放化疗对新诊断的胶质母细胞瘤患者有什么益处？一项多中心，随机，平行，开放标签的Ⅱ期临床试验
3. Phase 2 clinical trial of VAL-083 as first-line treatment in newly-diagnosed MGMT-unmethylated glioblastoma multiforme (GBM): Halfway report [J] . Chengcheng Guo, Qunying Yang, Jiawei Li, Glioma . 2019,第4期

机译：VAL-083作为新诊断的MGMT-非甲基化胶质母细胞瘤（GBM）一线治疗的2期临床试验：中途报告
4. Does Early Postsurgical Temozolomide Plus Concomitant Radiochemotherapy Regimen Have Any Benefit in Newly-diagnosed Glioblastoma Patients? A Multi-center Randomized Parallel Open-label Phase II Clinical Trial [O] . Ying Mao, Yu Yao, Li-Wei Zhang, 2015

机译：在新诊断的胶质母细胞瘤患者中早期的替莫唑胺和早期放化疗方案是否有益处？一项多中心随机平行开放标签的II期临床试验
5. Does Early Postsurgical Temozolomide Plus Concomitant Radiochemotherapy Regimen Have Any Benefit in Newly-diagnosed Glioblastoma Patients? A Multi-center, Randomized, Parallel, Open-label, Phase II Clinical Trial [O] . Ying Mao, Yu Yao, Li-Wei Zhang, 2015

机译：早期术后替莫唑胺加伴随放化疗方案是否对新诊断的胶质母细胞瘤患者有任何益处？多中心，随机，平行，开放标签，II期临床试验

P858 An open-label, multi-center trial of INO-5401 and INO-9012 delivered by electroporation (EP) in combination with cemiplimab in subjects with newly-diagnosed glioblastoma (GBM)

著录项

引文网络

相似文献

相关主题

期刊订阅